Dedicated to partnering with global healthcare companies and innovators At every stage, we navigate our clients to realize efficiencies in cost and time with our integrated and comprehensive solutions. In 2020 David Dockhorn, M.S., Ph.D., and Patrick Donnelly decided to fill a long-held gap in the MedTech industry. Bringing together the industry’s leading companies, they formed the first end-to-end, integrated service provider solely devoted to MedTech. In June 2021Private equity firm Summit Partners acquired Boston Healthcare Associates, Ximedica, and Quartesian, rolling them into Veranex. Experien Group came on board in July 2021 and IMMR joined in October 2021. Veranex then acquired Worrell in December 2021 followed by Medidee coming onboard in September 2022.
Veranex
Unlock to Claim this listing
Add / Modify Company
0.48
Overall Excellence Rating
Industry
Retail & WholesaleCategory
Chemical ManufacturingESG/Ethical Impact
Veranex’s consulting services to life sciences companies might include advising on sustainable and environmentally responsible practices in product development, manufacturing, and distribution. The company assist clients in evaluating and enhancing the sustainability of their supply chains, which could lead to reduced environmental impact. Veranex help clients navigate environmental regulations and standards relevant to the life sciences industry, contributing to better environmental practices. Veranex’s work in the life sciences industry indirectly contributes to improving public health through the development and quality assurance of pharmaceuticals, medical devices, and diagnostics. The company’s services enhance the quality and safety of products in the life sciences sector, positively impacting patients and consumers. Veranex’s governance structure likely includes a leadership team responsible for strategic decisions and ethical practices. The company uphold high ethical standards in its consulting services, ensuring compliance with regulatory requirements and ethical considerations. Veranex assist clients in adhering to regulatory standards, promoting good governance practices within the life sciences industry. Veranex’s ESG efforts contribute to its long-term financial success by enhancing its reputation, attracting responsible clients, and improving operational efficiency. The company’s specialization in life sciences consulting lead to sustained demand for its services, enhancing its financial performance. By helping clients optimize their operations, Veranex achieve cost savings and operational improvements. Strong ESG performance attract investors who prioritize companies with responsible and ethical business practices.
Eligible Awards
Coming Soon
Claim Your Award Badges
Do you work with Us
Awards Received
2023
Revenues
232500000.00
Website Traffic
Employee Rating
3.50
Customer Rating
4.30
Company Size
1000-5000
ESG Risk Rating
3.00